Potential Stem Cell Therapy for Coronavirus Infection

Golden, Colorado—February 27, 2020—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant.  While this therapy is not a method to eradicate or cure Coronavirus, there is...

Vitro Biopharma Company Overview

The US-based Vitro Biopharma is focused on achieving the full potential of regenerative medicine. Established in 1986, Vitro Biopharma provides a unique mix of research and clinical products used by leading universities and institutions worldwide. Over the last 25...

Vitro Biopharma Obtains CLIA Certification

Vitro Biopharma Obtains CLIA Certification Adding a New Dimension to its Ongoing Stem Cell Clinical Trials Golden, Colorado—April 2, 2019—Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma announced receipt of a Certificate of Compliance with CLIA (Clinical...